BEIS announces new partnership to respond to coronavirus (COVID-19) variants

BEIS announces new partnership to respond to coronavirus (COVID-19) variants

The Department for Business, Energy & Industrial Strategy (BEIS) has announced that the government and CureVac have entered into a new partnership to tackle variants of coronavirus (COVID-19). The new agreement is said to utilise UK expertise on genomics and virus sequencing to enable new varieties of vaccines based on RNA technology to be developed rapidly against new strains of coronavirus. Through this agreement, the UK has ordered 50 million doses of new vaccines, should they be required, to be delivered in late 2021.

The Secretary of State for Business, Energy and Industrial Strategy, Kwasi Kwarteng, said: 'This fantastic new partnership means we can work to swiftly tweak and rollout new variations of existing vaccines if we need to, while also building up Britain’s vaccine manufacturing base in the process.'

Source: New vaccines partnership to rapidly respond to new virus variants

Related Articles:
Latest Articles: